1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About

Kanisa Pharmaceuticals, Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2004

Location

San Diego CA US

Primary Industry

Pharmaceuticals

About

Based in San Diego, US and founded in 2004 by David A. Socks, Kanisa Pharmaceuticals, Inc. is a pharmaceutical company which is focused on the acquisition, development and commercialisation of therapeutics in the field of oncology.
Current Investors
InterWest Partners, New Enterprise Associates, Montreux Equity Partners

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Oncology/Cancer Treatment, Pharmaceutical Research & Development
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.